Abstract:The ideal food for new-borns is human breast milk, a mixture that provides a balanced combination of nutrients and bioactive components. Seeking to emulate maternal milk more effectively, this study assesses the impact of incorporating a multi-strain synbiotic and/or osteopontin (an active biopeptide) on the intestinal health of lactating pigs. Ninety-six weaned piglets were assigned to four dietary treatments in a 2x2 design. Treatments included: standard milk formula (CTR); CTR + probiotics (6.4x108 cfu/L Bifidobacterium longum subsp. infantis CECT 7210 and 1.1x108 cfu/L Lactobacillus rhamnosus NH001) + prebiotics (galacto-oligosaccharides 4.36 g/L and human-milk-oligosaccharide 0.54 g/L) (SYN); CTR + osteopontin (0.43 g/L) (OPN); and CTR + SYN + OPN (CON). Daily records including feed intake, body weight, and clinical signs, were maintained throughout the 15-day trial. Samples from blood, digestive content, and gut tissues were collected to determine serum TNF-α, intestinal fermentation (SCFA and ammonia), colonic microbiota (16S rRNA Illumina-MiSeq), histomorphology, and jejunal gene expression (Open-Array). No statistical differences were found in weight gain; however, animals supplemented with osteopontin exhibited higher feed intake. Regarding clinical signs, synbiotic supplementation led to shorter duration of diarrhoea episodes. The sequenced faecal microbiota revealed better control of potentially dysbiotic bacteria with CON diet at day 15. In colon compartment, an increase in SCFA concentration, a decrease in ammonia concentration, and a decrease in intraepithelial lymphocyte counts were observed in CON animals. Supplemented diets were also associated with modified jejunal gene expression. The synbiotic combination exhibited an upregulation of genes related to intestinal maturation (ALPI, SI) and nutrient transport (SLC13A1, SLC15A1, SLC5A1, SLC7A8), and downregulation of genes related to the response to pathogens (GBP1, TLR4) or inflammatory response (IDO, IL-1β, TGF-β1). Osteopontin promoted an upregulation of a digestive function gene (GCG). Correlational analysis between the microbiota population and various intestinal environmental factors (SCFA concentration, histology, and gene expression) proposes mechanisms of communication between the gut microbiota and the host. In summary, these results suggest an improvement in the colonic colonization process and a better modulation of the immune response when milk formula is supplemented with the tested synbiotic combined with osteopontin, benefiting from a synergistic effect.

Osteopontin Associated Bifidobacterium Bifidum Microencapsulation Modulates Infant Fecal Fermentation and Gut Microbiota Development

Osteopontin Enhances the Probiotic Viability of Bifidobacteria in Pectin-Based Microencapsulation Subjected to in Vitro Infant Gastrointestinal Digestion

Preparation and synbiotic interaction mechanism of microcapsules of Bifidobacterium animalis F1-7 and human milk oligosaccharides (HMO)

Enhanced Viability of Probiotics (pediococcus Pentosaceus Li05) by Encapsulation in Microgels Doped with Inorganic Nanoparticles

Supplementing infant milk formula with a multi-strain synbiotic and osteopontin enhances colonic microbial colonization and modifies jejunal gene expression in lactating piglets

Enhanced Gut Microbiota Delivery of a Model Probiotic (faecalibacterium Prausnitzii): Layer-by-layer Encapsulation Using Riboflavin-Conjugated Sodium Alginate and Glycol Chitosan

Gastro-Intestinal Digested Bovine Milk Osteopontin Modulates Gut Barrier Biomarkers In Vitro

Encapsulation of bifidobacterium in alginate microgels improves viability and targeted gut release

Supplementation of microencapsulated probiotics modulates gut health and intestinal microbiota

Protein-polysaccharide based double network microbeads improves stability of Bifidobacterium infantis ATCC 15697 in a gastro-Intestinal Tract Model (TIM-1)

Encapsulation of Lactobacillus in Low-Methoxyl Pectin-Based Microcapsules Stimulates Biofilm Formation: Enhanced Resistances to Heat Shock and Simulated Gastrointestinal Digestion

Proliferation of Bifidobacterium L80 under different proportions of milk protein hydrolysate

In-vitro GIT Tolerance of Microencapsulated Bifidobacterium bifidum ATCC 35914 Using Polysaccharide-Protein Matrix

Synbiotic microencapsulation of Lactobacillus brevis and Lactobacillus delbrueckii subsp. lactis using oats/oats brans as prebiotic for enhanced storage stability

Development of a novel probiotic delivery system based on microencapsulation with protectants

Effects of 1, 3-dioleoyl-2-palmitoylglycerol and its plant-oil formula on the toddler fecal microbiota during in vitro fermentation

Microencapsulation protected Lactobacillus viability and its activity in modulating the intestinal microbiota in newly weaned piglets

Symbiotic microparticles produced through spray-drying-induced in situ alginate crosslinking for the preservation of Pediococcus pentosaceus viability

Enhance the resistance of probiotics by microencapsulation and biofilm construction based on rhamnogalacturonan I rich pectin

Preparation and characterization of pectin-alginate-based microbeads reinforced by nano montmorillonite filler for probiotics encapsulation: Improving viability and colonic colonization

Effect of the Encapsulation Process on the Viability of Probiotics in a Simulated Gastrointestinal Tract Model Medium